— Know what they know.
Not Investment Advice

300406.SZ SHZ

Beijing Strong Biotechnologies, Inc.
1W: +1.3% 1M: +3.2% 3M: +6.5% YTD: -10.4% 1Y: -17.1% 3Y: -39.8% 5Y: -29.5%
¥11.94 ($1.78)
+0.17 (+1.44%)
 
SHZ · Healthcare · Medical - Diagnostics & Research · Tech Score Buy · Power 60 · ¥7.0B mcap · 330M float · 1.46% daily turnover

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 58 Grade A
Profitability
69
Balance Sheet
81
Earnings Quality
61
Growth
13
Value
60
Momentum
49
Safety
100
Cash Flow
78
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. 300406.SZ scores highest in Safety (100/100) and lowest in Growth (13/100). An overall grade of A places 300406.SZ among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
4.72
Safe Zone
Piotroski F-Score
5/9
✓ ✓ ✗ ✓ ✗ ✓ ✓ ✗ ✗
Beneish M-Score
-2.82
Unlikely Manipulator
Ohlson O-Score
-10.11
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA+
Score: 90.5/100
Trend: Stable
Earnings Quality
75/100
OCF/NI: 2.57x
Accruals: -6.8%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. 300406.SZ scores 4.72, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. 300406.SZ scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. 300406.SZ's score of -2.82 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. 300406.SZ's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. 300406.SZ receives an estimated rating of AA+ (score: 90.5/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). 300406.SZ's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
30.62x
PEG
-0.61x
P/S
5.12x
P/B
1.94x
P/FCF
11.57x
P/OCF
11.03x
EV/EBITDA
11.75x
EV/Revenue
4.88x
EV/EBIT
12.97x
EV/FCF
12.11x
Earnings Yield
3.53%
FCF Yield
8.65%
Shareholder Yield
11.54%
Graham Number
$7.31
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 30.6x earnings, 300406.SZ commands a growth premium. Graham's intrinsic value formula yields $7.31 per share, 63% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.802
NI / EBT
×
Interest Burden
0.545
EBT / EBIT
×
EBIT Margin
0.376
EBIT / Rev
×
Asset Turnover
0.265
Rev / Assets
×
Equity Multiplier
1.345
Assets / Equity
=
ROE
5.9%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. 300406.SZ's ROE of 5.9% is driven by a balanced combination of operating margin, asset efficiency, and leverage.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$3.28
Price/Value
3.33x
Margin of Safety
-233.13%
Premium
233.13%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with 300406.SZ's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. 300406.SZ trades at a 233% premium to its adjusted intrinsic value of $3.28, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 30.6x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$11.94
Median 1Y
$10.82
5th Pctile
$5.60
95th Pctile
$20.85
Ann. Volatility
41.0%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 10.1% 13.4% 12.5% 10.9% 11.0% 12.7% 12.7% 14.5% 14.6% 15.0% 14.8% 14.5% 13.9% 13.5% 12.3% 11.5% 10.8% 4.8% 5.2% 5.9% 5.87%
ROA 7.7% 9.8% 9.4% 8.1% 7.8% 8.7% 8.9% 10.2% 10.3% 10.7% 10.7% 10.6% 10.1% 9.9% 9.1% 8.5% 8.0% 3.6% 3.9% 4.4% 4.36%
ROIC 10.4% 13.0% 11.5% 9.9% 9.5% 9.9% 9.8% 11.0% 11.4% 12.6% 13.4% 13.7% 12.8% 12.6% 11.5% 10.6% 10.2% 4.6% 5.1% 6.1% 6.09%
ROCE 11.0% 14.8% 13.7% 12.2% 11.3% 11.6% 11.5% 12.2% 12.7% 12.4% 12.3% 12.8% 12.2% 12.0% 11.0% 9.8% 9.5% 9.4% 9.7% 11.0% 10.95%
Gross Margin 73.7% 72.0% 70.7% 75.0% 76.3% 76.1% 74.6% 74.6% 77.6% 71.6% 76.9% 77.8% 78.8% 79.3% 80.8% 78.4% 80.4% 77.8% 81.9% 76.6% 76.56%
Operating Margin 30.7% 28.7% 31.4% 23.0% 29.8% 35.6% 34.7% 32.1% 35.9% 33.9% 36.7% 37.0% 33.9% 42.8% 30.7% 28.3% 35.3% -20.9% 37.0% 35.3% 35.31%
Net Margin 21.8% 24.9% 26.3% 19.1% 25.9% 30.8% 29.7% 29.5% 31.1% 30.0% 30.6% 30.3% 29.6% 37.8% 26.0% 26.4% 28.3% -24.0% 31.5% 30.4% 30.45%
EBITDA Margin 30.6% 34.5% 37.1% 33.4% 32.8% 41.6% 40.7% 35.9% 42.3% 33.3% 42.6% 43.8% 39.2% 42.9% 38.8% 30.9% 35.8% 45.4% 44.4% 40.6% 40.63%
FCF Margin 16.3% 17.8% 18.0% 20.5% 21.0% 19.8% 19.8% 17.6% 22.4% 24.4% 24.6% 30.9% 31.0% 34.0% 39.8% 39.4% 41.8% 38.8% 40.8% 40.3% 40.32%
OCF Margin 18.3% 21.9% 23.8% 27.0% 28.5% 26.2% 26.3% 25.2% 30.5% 32.9% 33.3% 37.7% 36.8% 38.3% 42.9% 42.4% 44.5% 41.7% 43.0% 42.3% 42.27%
ROE 3Y Avg snapshot only 10.43%
ROE 5Y Avg snapshot only 11.28%
ROA 3Y Avg snapshot only 7.69%
ROIC 3Y Avg snapshot only 9.06%
ROIC Economic snapshot only 5.09%
Cash ROA snapshot only 11.85%
Cash ROIC snapshot only 14.86%
CROIC snapshot only 14.18%
NOPAT Margin snapshot only 17.33%
Pretax Margin snapshot only 20.53%
R&D / Revenue snapshot only 12.79%
SGA / Revenue snapshot only 29.16%
SBC / Revenue snapshot only 0.00%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 26.48 26.48 24.76 27.15 25.08 22.94 28.30 27.25 22.17 19.88 19.25 15.91 15.57 14.09 17.59 17.54 17.87 40.61 32.70 28.32 30.615
P/S Ratio 5.77 6.72 6.07 6.27 6.07 5.91 7.53 7.89 6.71 5.98 5.83 4.85 4.69 4.52 5.50 5.33 5.38 5.69 5.06 4.66 5.124
P/B Ratio 2.56 3.74 3.26 3.16 2.90 2.73 3.36 3.67 3.04 2.79 2.67 2.20 2.06 1.81 2.06 1.97 1.93 2.04 1.78 1.78 1.939
P/FCF 35.34 37.72 33.69 30.56 28.98 29.79 38.08 44.82 29.96 24.47 23.69 15.70 15.11 13.30 13.82 13.53 12.88 14.66 12.43 11.57 11.566
P/OCF 31.48 30.69 25.50 23.19 21.33 22.53 28.62 31.30 22.04 18.15 17.50 12.86 12.74 11.81 12.83 12.56 12.10 13.64 11.77 11.03 11.032
EV/EBITDA 18.57 19.66 18.81 20.12 19.22 17.69 21.67 22.35 17.87 16.46 15.46 12.17 12.16 10.86 13.41 14.37 15.00 16.13 13.74 11.75 11.750
EV/Revenue 6.07 7.18 6.58 6.80 6.62 6.41 8.05 8.41 7.15 6.21 5.90 4.88 4.79 4.58 5.55 5.50 5.61 6.08 5.37 4.88 4.881
EV/EBIT 19.87 20.95 20.22 21.87 20.99 19.33 23.74 24.35 19.45 17.90 16.79 13.24 13.26 11.90 14.87 16.19 16.59 17.95 15.22 12.97 12.969
EV/FCF 37.16 40.33 36.53 33.14 31.56 32.33 40.74 47.74 31.95 25.43 24.00 15.80 15.43 13.45 13.94 13.95 13.42 15.67 13.17 12.11 12.105
Earnings Yield 3.8% 3.8% 4.0% 3.7% 4.0% 4.4% 3.5% 3.7% 4.5% 5.0% 5.2% 6.3% 6.4% 7.1% 5.7% 5.7% 5.6% 2.5% 3.1% 3.5% 3.53%
FCF Yield 2.8% 2.7% 3.0% 3.3% 3.5% 3.4% 2.6% 2.2% 3.3% 4.1% 4.2% 6.4% 6.6% 7.5% 7.2% 7.4% 7.8% 6.8% 8.0% 8.6% 8.65%
Price/Tangible Book snapshot only 3.122
EV/OCF snapshot only 11.547
EV/Gross Profit snapshot only 6.166
Acquirers Multiple snapshot only 22.613
Shareholder Yield snapshot only 11.54%
Graham Number snapshot only $7.31
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 3.37 2.87 3.37 3.48 5.31 6.94 9.09 9.46 9.15 7.86 11.08 10.36 9.03 9.28 10.57 11.73 11.66 12.84 12.18 11.85 11.851
Quick Ratio 2.90 2.45 2.92 3.04 4.72 6.20 8.06 8.51 8.25 7.08 10.12 9.46 8.21 8.49 9.62 10.66 10.63 11.75 11.20 10.77 10.766
Debt/Equity 0.21 0.39 0.36 0.36 0.36 0.34 0.33 0.33 0.31 0.30 0.30 0.31 0.29 0.27 0.27 0.28 0.27 0.28 0.28 0.30 0.303
Net Debt/Equity 0.13 0.26 0.28 0.27 0.26 0.23 0.23 0.24 0.20 0.11 0.04 0.01 0.04 0.02 0.02 0.06 0.08 0.14 0.11 0.08 0.083
Debt/Assets 0.15 0.26 0.25 0.25 0.25 0.24 0.24 0.24 0.23 0.22 0.22 0.23 0.21 0.20 0.20 0.21 0.20 0.21 0.21 0.22 0.223
Debt/EBITDA 1.45 1.93 1.92 2.12 2.21 2.01 1.99 1.87 1.73 1.72 1.74 1.73 1.70 1.62 1.74 1.96 1.99 2.09 2.04 1.92 1.917
Net Debt/EBITDA 0.91 1.27 1.46 1.57 1.57 1.39 1.41 1.37 1.11 0.62 0.20 0.08 0.25 0.12 0.12 0.43 0.60 1.03 0.78 0.52 0.524
Interest Coverage 36.66 25.39 16.25 11.15 9.03 9.52 10.57 11.72 13.58 13.86 13.30 13.92 13.34 13.40 12.37 10.64 10.02 9.29 9.68 10.14 10.143
Equity Multiplier 1.38 1.50 1.45 1.45 1.45 1.41 1.39 1.38 1.39 1.39 1.37 1.37 1.37 1.35 1.33 1.33 1.32 1.33 1.33 1.36 1.358
Cash Ratio snapshot only 4.442
Debt Service Coverage snapshot only 11.195
Cash to Debt snapshot only 0.727
FCF to Debt snapshot only 0.506
Defensive Interval snapshot only 874.5 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.35 0.39 0.38 0.35 0.32 0.34 0.34 0.35 0.34 0.36 0.35 0.35 0.33 0.31 0.29 0.28 0.27 0.26 0.25 0.26 0.265
Inventory Turnover 1.87 1.80 1.94 1.79 1.69 1.63 1.60 1.78 1.71 1.98 1.85 1.91 1.80 1.61 1.42 1.39 1.29 1.37 1.33 1.37 1.366
Receivables Turnover 1.80 1.92 1.80 1.67 1.56 1.57 1.51 1.59 1.59 1.62 1.59 1.58 1.55 1.49 1.43 1.38 1.30 1.30 1.27 1.30 1.303
Payables Turnover 5.94 10.03 10.02 9.22 7.70 9.06 9.14 8.72 9.19 7.46 5.99 5.92 5.74 4.79 4.20 4.05 3.92 4.62 5.38 5.37 5.370
DSO 203 190 203 219 234 233 242 230 229 226 229 231 235 244 256 265 281 281 288 280 280.2 days
DIO 196 203 188 204 216 224 228 205 213 184 198 192 203 227 258 263 283 266 275 267 267.1 days
DPO 61 36 36 40 47 40 40 42 40 49 61 62 64 76 87 90 93 79 68 68 68.0 days
Cash Conversion Cycle 337 357 355 383 403 417 431 393 403 361 366 361 374 395 427 437 471 468 495 479 479.4 days
Fixed Asset Turnover snapshot only 2.634
Operating Cycle snapshot only 547.4 days
Cash Velocity snapshot only 1.728
Capital Intensity snapshot only 3.567
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 93.2% 88.6% 44.1% 8.1% -2.3% -5.5% -5.4% 7.4% 7.9% 15.3% 16.6% 8.2% 7.6% -4.7% -10.1% -13.8% -17.9% -18.3% -13.5% -9.3% -9.28%
Net Income 66.3% 2.6% 85.0% 16.0% 8.6% -4.1% 2.7% 34.7% 34.8% 34.6% 32.7% 13.8% 7.1% 1.7% -7.1% -14.1% -17.9% -64.4% -57.1% -50.8% -50.83%
EPS 51.1% 3.0% 89.2% 13.3% 8.6% -4.1% 1.4% 34.5% 34.9% 34.7% 34.9% 14.1% 7.1% -0.2% -10.3% -14.1% -17.6% -63.8% -56.6% -50.4% -50.36%
FCF 2.1% 1.7% 1.5% 56.7% 25.4% 5.2% 3.8% -7.8% 15.3% 42.0% 45.1% 89.8% 49.1% 32.7% 45.5% 9.9% 10.6% -6.8% -11.4% -7.1% -7.15%
EBITDA 96.5% 2.1% 70.9% 11.6% 2.9% -6.2% 0.5% 19.5% 25.5% 20.0% 19.8% 15.3% 5.8% 6.3% -2.6% -17.8% -22.0% -26.9% -18.3% -1.5% -1.47%
Op. Income 86.2% 2.5% 73.8% 6.0% -6.5% -15.0% -6.1% 23.6% 31.3% 30.4% 30.1% 17.4% 10.0% 5.1% -5.1% -17.0% -19.0% -60.5% -52.9% -43.1% -43.11%
OCF Growth snapshot only -9.62%
Asset Growth snapshot only -10.47%
Equity Growth snapshot only -12.02%
Debt Growth snapshot only -3.57%
Shares Change snapshot only -0.95%
Dividend Growth snapshot only 1.94%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 26.8% 27.4% 26.8% 24.1% 22.7% 21.6% 24.6% 29.0% 26.8% 27.1% 16.7% 7.9% 4.3% 1.2% -0.3% 0.0% -1.6% -3.6% -3.2% -5.4% -5.44%
Revenue 5Y 19.0% 19.1% 19.4% 17.9% 18.0% 16.8% 16.1% 16.6% 16.5% 17.6% 17.6% 17.3% 16.5% 14.6% 15.2% 14.9% 12.5% 9.8% 4.3% -0.4% -0.36%
EPS 3Y 0.1% 14.1% 4.0% -1.7% -1.1% -0.7% 0.9% 23.2% 30.3% 72.4% 37.3% 20.3% 16.2% 8.8% 7.1% 9.7% 6.0% -21.3% -19.3% -21.3% -21.34%
EPS 5Y 2.0% 5.9% 5.5% 2.7% 2.8% 2.2% 4.3% 7.1% 8.0% 13.9% 9.0% 7.8% 6.9% 5.6% 4.5% 12.9% 14.3% 13.1% 0.2% -5.8% -5.80%
Net Income 3Y 5.6% 10.5% 8.9% 3.0% 4.0% 5.5% 12.3% 26.0% 34.6% 67.1% 36.1% 21.2% 16.2% 9.5% 8.1% 9.6% 5.8% -21.3% -19.2% -21.7% -21.66%
Net Income 5Y 4.7% 8.4% 8.6% 6.0% 6.5% 7.3% 7.5% 10.9% 11.5% 11.7% 12.0% 10.9% 10.2% 9.9% 11.8% 14.3% 16.4% 11.1% 0.0% -5.6% -5.55%
EBITDA 3Y 13.5% 19.4% 17.3% 11.9% 12.3% 13.1% 19.4% 29.4% 36.4% 51.3% 27.2% 15.4% 11.0% 6.2% 5.4% 4.2% 1.2% -2.3% -1.6% -2.3% -2.25%
EBITDA 5Y 10.8% 13.6% 13.4% 10.9% 10.5% 10.9% 11.1% 12.8% 13.6% 13.9% 14.2% 14.1% 13.5% 13.0% 14.7% 15.5% 15.9% 21.9% 10.4% 4.5% 4.48%
Gross Profit 3Y 27.4% 29.5% 29.0% 26.2% 25.9% 25.0% 29.4% 36.1% 34.4% 35.6% 22.8% 12.0% 7.2% 4.1% 2.8% 2.9% 1.1% -1.5% -1.5% -3.9% -3.88%
Gross Profit 5Y 19.6% 20.3% 20.4% 18.9% 18.2% 17.7% 17.6% 18.6% 18.7% 19.6% 19.7% 19.4% 19.1% 17.6% 18.9% 19.8% 17.7% 15.7% 8.9% 2.8% 2.82%
Op. Income 3Y 10.9% 15.6% 12.5% 5.3% 4.5% 6.4% 12.6% 25.2% 31.7% 57.1% 28.5% 15.4% 10.5% 5.2% 5.0% 6.4% 5.3% -18.5% -16.5% -17.9% -17.87%
Op. Income 5Y 8.3% 11.5% 10.7% 7.4% 6.6% 7.1% 7.3% 10.3% 10.8% 11.3% 11.7% 11.2% 10.5% 10.6% 12.0% 13.9% 15.3% 10.0% -1.0% -6.2% -6.20%
FCF 3Y 10.7% 15.9% 21.1% 21.7% 33.1% 33.1% 41.1% 61.7% 65.4% 59.0% 56.6% 40.0% 29.2% 25.6% 29.9% 24.3% 23.9% 20.6% 23.2% 24.6% 24.64%
FCF 5Y 11.9% 11.3% 9.3% 9.9% 13.4% 10.4% 11.4% 11.0% 14.4% 18.4% 21.7% 25.8% 32.3% 34.7% 42.8% 54.5% 49.5% 37.8% 37.7% 22.8% 22.84%
OCF 3Y 3.9% 11.0% 16.7% 18.1% 30.3% 28.1% 37.2% 52.5% 60.6% 67.0% 64.3% 43.7% 31.6% 22.0% 21.3% 16.2% 14.2% 12.6% 14.1% 12.3% 12.33%
OCF 5Y 4.4% 7.6% 8.4% 10.1% 15.9% 13.8% 13.8% 14.2% 14.4% 17.5% 19.6% 21.7% 27.1% 27.5% 34.6% 41.0% 39.8% 35.7% 34.8% 21.0% 21.05%
Assets 3Y 39.1% 32.3% 32.6% 32.8% 32.8% 28.9% 28.1% 29.5% 8.5% 9.3% 9.3% 8.2% 4.4% 8.9% 9.4% 7.8% 5.0% 3.1% 3.4% 0.5% 0.52%
Assets 5Y 28.3% 24.0% 22.9% 24.2% 24.3% 21.0% 22.0% 23.4% 22.8% 22.7% 23.4% 23.4% 22.8% 20.9% 20.4% 19.8% 6.4% 5.0% 5.1% 3.1% 3.07%
Equity 3Y 29.5% 19.1% 18.9% 19.2% 19.4% 18.4% 19.4% 21.5% 4.1% 5.2% 5.2% 4.6% 4.6% 12.9% 12.4% 10.9% 8.3% 5.0% 4.8% 1.1% 1.11%
Book Value 3Y 22.8% 23.0% 13.5% 13.7% 13.5% 11.5% 7.3% 18.8% 0.9% 8.6% 6.1% 3.8% 4.7% 12.2% 11.3% 11.0% 8.4% 4.9% 4.7% 1.5% 1.52%
Dividend 3Y -8.7% 1.7% -2.9% 7.6% 6.4% 16.4% 4.0% 6.9% 4.6% -2.4% -2.7% 11.4% 13.2% -1.0% -0.8% 10.3% 32.3% 62.8% 62.6% 43.4% 43.38%
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.58 0.60 0.75 0.76 0.75 0.74 0.83 0.83 0.79 0.81 0.91 0.94 0.84 0.75 0.68 0.66 0.57 0.41 0.26 0.00 0.000
Earnings Stability 0.04 0.01 0.16 0.30 0.23 0.12 0.35 0.54 0.52 0.38 0.64 0.76 0.74 0.59 0.79 0.82 0.70 0.08 0.03 0.00 0.000
Margin Stability 0.96 0.94 0.96 0.95 0.94 0.93 0.94 0.94 0.93 0.92 0.93 0.95 0.95 0.95 0.94 0.92 0.92 0.90 0.92 0.94 0.937
Rev. Growth Consistency 0.50 1.00 1.00 1.00 0.00 0.00 0.00 1.00 0.50 0.50 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.50 0.50 0.50 1.00 1.00 0.00 1.00 1.00 1.00 0.50 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.50 0.94 0.97 0.98 0.99 0.86 0.86 0.86 0.87 0.94 0.97 0.99 0.97 0.94 0.93 0.50 0.50 0.50 0.500
Earnings Smoothness 0.50 0.00 0.40 0.85 0.92 0.96 0.97 0.70 0.70 0.70 0.72 0.87 0.93 0.98 0.93 0.85 0.80 0.05 0.20 0.32 0.318
ROE Trend -0.02 0.04 0.03 0.01 0.04 0.03 0.02 0.03 0.03 0.01 0.01 0.01 0.01 -0.00 -0.01 -0.02 -0.03 -0.08 -0.07 -0.06 -0.062
Gross Margin Trend 0.04 0.07 0.06 0.07 0.07 0.08 0.07 0.05 0.04 0.01 0.01 0.02 0.01 0.04 0.04 0.04 0.04 0.03 0.03 0.02 0.017
FCF Margin Trend 0.03 0.04 0.06 0.09 0.08 0.05 0.06 0.00 0.04 0.06 0.06 0.12 0.09 0.12 0.18 0.15 0.15 0.10 0.09 0.05 0.052
Sustainable Growth Rate 8.0% 10.8% 9.6% 7.8% 8.0% 7.8% 8.3% 10.5% 10.9% 11.4% 11.3% 9.5% 9.1% 10.4% 9.2% 5.3% 0.3% -8.8% -8.0% -12.8% -12.82%
Internal Growth Rate 6.5% 8.6% 7.8% 6.2% 6.0% 5.7% 6.3% 8.0% 8.3% 8.9% 9.0% 7.4% 7.1% 8.2% 7.3% 4.1% 0.2% — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.84 0.86 0.97 1.17 1.18 1.02 0.99 0.87 1.01 1.09 1.10 1.24 1.22 1.19 1.37 1.40 1.48 2.98 2.78 2.57 2.567
FCF/OCF 0.89 0.81 0.76 0.76 0.74 0.76 0.75 0.70 0.74 0.74 0.74 0.82 0.84 0.89 0.93 0.93 0.94 0.93 0.95 0.95 0.954
FCF/Net Income snapshot only 2.448
OCF/EBITDA snapshot only 1.018
CapEx/Revenue 2.0% 4.1% 5.8% 6.5% 7.5% 6.4% 6.5% 7.6% 8.1% 8.5% 8.7% 6.8% 5.6% 4.1% 2.9% 2.8% 2.7% 2.9% 2.3% 1.9% 1.95%
CapEx/Depreciation snapshot only 0.499
Accruals Ratio 0.01 0.01 0.00 -0.01 -0.01 -0.00 0.00 0.01 -0.00 -0.01 -0.01 -0.03 -0.02 -0.02 -0.03 -0.03 -0.04 -0.07 -0.07 -0.07 -0.068
Sloan Accruals snapshot only -0.070
Cash Flow Adequacy snapshot only 0.777
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.8% 0.7% 0.9% 1.1% 1.1% 1.7% 1.2% 1.0% 1.2% 1.2% 1.2% 2.2% 2.2% 1.7% 1.4% 3.1% 5.5% 7.0% 7.7% 11.2% 8.79%
Dividend/Share $0.12 $0.13 $0.15 $0.17 $0.17 $0.25 $0.24 $0.22 $0.21 $0.21 $0.22 $0.31 $0.31 $0.21 $0.21 $0.42 $0.72 $0.91 $0.92 $1.23 $1.05
Payout Ratio 21.2% 19.4% 22.7% 28.6% 27.4% 38.1% 34.2% 27.7% 25.6% 24.0% 23.2% 34.5% 34.7% 23.3% 25.1% 53.8% 97.5% 2.8% 2.5% 3.2% 3.18%
FCF Payout Ratio 28.3% 27.6% 30.8% 32.2% 31.7% 49.5% 46.1% 45.6% 34.7% 29.6% 28.5% 34.0% 33.7% 22.0% 19.7% 41.5% 70.3% 1.0% 96.1% 1.3% 1.30%
Total Payout Ratio 21.2% 19.4% 22.7% 33.2% 27.4% 3.4% 3.3% 2.8% 2.7% 33.4% 32.4% 44.4% 44.1% 23.3% 25.1% 54.8% 97.5% 2.8% 2.5% 3.3% 3.27%
Div. Increase Streak 0 0 1 0 0 0 1 1 1 0 0 1 1 0 0 1 1 0 1 1 1
Chowder Number -0.10 -0.04 0.06 0.45 0.41 0.90 0.56 0.32 0.27 -0.14 -0.09 0.44 0.47 0.00 0.02 0.37 1.36 3.39 3.39 2.02 2.024
Buyback Yield 0.0% 0.0% 0.0% 0.2% 0.0% 13.2% 10.4% 9.2% 10.8% 0.5% 0.5% 0.6% 0.6% 0.0% 0.0% 0.1% 0.0% 0.0% 0.0% 0.3% 0.29%
Net Buyback Yield 0.0% 0.0% 0.0% 0.2% -0.2% 13.0% 10.2% 9.2% 10.8% 0.5% 0.5% 0.5% 0.6% 0.0% 0.0% 0.1% 0.0% 0.0% 0.0% 0.3% 0.29%
Total Shareholder Return 0.8% 0.7% 0.9% 1.2% 0.9% 14.7% 11.4% 10.2% 12.0% 1.7% 1.7% 2.7% 2.8% 1.7% 1.4% 3.1% 5.5% 7.0% 7.7% 11.5% 11.54%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.75 0.76 0.78 0.81 0.86 0.87 0.87 0.89 0.88 0.88 0.88 0.86 0.86 0.86 0.86 0.89 0.89 0.80 0.81 0.80 0.802
Interest Burden (EBT/EBIT) 0.95 0.98 0.96 0.92 0.90 0.90 0.90 0.94 0.93 0.98 0.98 0.97 0.97 0.97 0.98 1.01 1.00 0.51 0.54 0.55 0.545
EBIT Margin 0.31 0.34 0.33 0.31 0.32 0.33 0.34 0.35 0.37 0.35 0.35 0.37 0.36 0.38 0.37 0.34 0.34 0.34 0.35 0.38 0.376
Asset Turnover 0.35 0.39 0.38 0.35 0.32 0.34 0.34 0.35 0.34 0.36 0.35 0.35 0.33 0.31 0.29 0.28 0.27 0.26 0.25 0.26 0.265
Equity Multiplier 1.31 1.36 1.33 1.34 1.41 1.45 1.42 1.42 1.42 1.40 1.38 1.38 1.38 1.37 1.35 1.35 1.35 1.34 1.33 1.35 1.345
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $0.57 $0.69 $0.68 $0.59 $0.62 $0.66 $0.69 $0.79 $0.83 $0.89 $0.93 $0.91 $0.89 $0.89 $0.83 $0.78 $0.74 $0.32 $0.36 $0.39 $0.39
Book Value/Share $5.88 $4.88 $5.15 $5.07 $5.35 $5.56 $5.79 $5.89 $6.08 $6.33 $6.70 $6.55 $6.75 $6.90 $7.10 $6.93 $6.82 $6.42 $6.63 $6.16 $6.15
Tangible Book/Share $2.92 $1.92 $2.12 $2.11 $2.40 $2.60 $2.82 $2.94 $3.14 $3.38 $3.68 $3.61 $3.81 $4.02 $4.19 $4.00 $3.88 $3.79 $3.99 $3.50 $3.50
Revenue/Share $2.61 $2.72 $2.77 $2.55 $2.55 $2.57 $2.59 $2.74 $2.76 $2.96 $3.07 $2.97 $2.97 $2.77 $2.66 $2.56 $2.44 $2.30 $2.34 $2.34 $2.34
FCF/Share $0.43 $0.48 $0.50 $0.52 $0.54 $0.51 $0.51 $0.48 $0.62 $0.72 $0.75 $0.92 $0.92 $0.94 $1.06 $1.01 $1.02 $0.89 $0.95 $0.95 $0.95
OCF/Share $0.48 $0.59 $0.66 $0.69 $0.73 $0.67 $0.68 $0.69 $0.84 $0.97 $1.02 $1.12 $1.09 $1.06 $1.14 $1.09 $1.09 $0.96 $1.01 $0.99 $0.99
Cash/Share $0.46 $0.65 $0.44 $0.47 $0.56 $0.58 $0.55 $0.52 $0.68 $1.23 $1.80 $1.97 $1.69 $1.74 $1.79 $1.49 $1.27 $0.91 $1.15 $1.36 $1.36
EBITDA/Share $0.85 $0.99 $0.97 $0.86 $0.88 $0.93 $0.96 $1.03 $1.10 $1.12 $1.17 $1.19 $1.17 $1.16 $1.10 $0.98 $0.91 $0.87 $0.91 $0.97 $0.97
Debt/Share $1.24 $1.91 $1.86 $1.83 $1.94 $1.87 $1.91 $1.93 $1.91 $1.92 $2.03 $2.06 $1.98 $1.88 $1.91 $1.92 $1.82 $1.81 $1.86 $1.87 $1.87
Net Debt/Share $0.78 $1.26 $1.42 $1.36 $1.38 $1.29 $1.36 $1.41 $1.23 $0.69 $0.23 $0.09 $0.29 $0.14 $0.13 $0.42 $0.55 $0.90 $0.71 $0.51 $0.51
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 4.720
Altman Z-Prime snapshot only 10.014
Piotroski F-Score 5 6 6 6 7 7 5 6 9 8 9 9 7 6 5 7 7 5 6 5 5
Beneish M-Score -2.04 -2.20 -2.36 -2.48 -2.66 -2.46 -2.41 -2.25 -2.38 -2.35 -2.52 -2.59 -2.41 -2.58 -2.58 -2.62 -2.83 -2.87 -2.88 -2.82 -2.824
Ohlson O-Score snapshot only -10.114
ROIC (Greenblatt) snapshot only 20.99%
Net-Net WC snapshot only $1.41
EVA snapshot only $-151790642.61
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only AA+
Credit Score 93.80 90.33 90.27 86.97 84.47 85.24 89.04 89.21 90.68 90.89 91.01 91.13 91.02 91.13 89.65 89.75 90.05 88.30 85.80 90.51 90.511
Credit Grade snapshot only 2
Credit Trend snapshot only 0.761
Implied Spread (bps) snapshot only 65.000
Industry Credit Rank snapshot only 86
Sector Credit Rank snapshot only 86

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms